These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 12717839)
1. Tumor necrosis factor-related apoptosis-inducing ligand gene on human colorectal cancer cell line HT29. Xu XM; He C; Hu XT; Fang BL World J Gastroenterol; 2003 May; 9(5):965-9. PubMed ID: 12717839 [TBL] [Abstract][Full Text] [Related]
2. [Action of apoptosis-induced ligand gene in relation to tumor necrosis factor on human colon cancer cell line HT29]. He C; Hu X; Xu X; Fang B Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):133-6. PubMed ID: 12015033 [TBL] [Abstract][Full Text] [Related]
3. Fiber-modified adenoviral vector expressing the tumor necrosis factor-related apoptosis-inducing ligand gene from the human telomerase reverse transcriptase promoter induces apoptosis in human hepatocellular carcinoma cells. Jacob D; Schumacher G; Bahra M; Davis J; Zhu HB; Zhang LD; Teraishi F; Neuhaus P; Fang BL World J Gastroenterol; 2005 May; 11(17):2552-6. PubMed ID: 15849810 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line. Zhang L; Gu J; Lin T; Huang X; Roth JA; Fang B Gene Ther; 2002 Sep; 9(18):1262-70. PubMed ID: 12215894 [TBL] [Abstract][Full Text] [Related]
5. Anti-liver cancer activity of TNF-related apoptosis-inducing ligand gene and its bystander effects. He C; Lao WF; Hu XT; Xu XM; Xu J; Fang BL World J Gastroenterol; 2004 Mar; 10(5):654-9. PubMed ID: 14991932 [TBL] [Abstract][Full Text] [Related]
6. Cancer gene therapy using a novel secretable trimeric TRAIL. Kim CY; Jeong M; Mushiake H; Kim BM; Kim WB; Ko JP; Kim MH; Kim M; Kim TH; Robbins PD; Billiar TR; Seol DW Gene Ther; 2006 Feb; 13(4):330-8. PubMed ID: 16195699 [TBL] [Abstract][Full Text] [Related]
7. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy. Zhang Y; Gu J; Zhao L; He L; Qian W; Wang J; Wang Y; Qian Q; Qian C; Wu J; Liu XY Cancer Res; 2006 Apr; 66(8):4291-8. PubMed ID: 16618754 [TBL] [Abstract][Full Text] [Related]
9. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Kagawa S; He C; Gu J; Koch P; Rha SJ; Roth JA; Curley SA; Stephens LC; Fang B Cancer Res; 2001 Apr; 61(8):3330-8. PubMed ID: 11309289 [TBL] [Abstract][Full Text] [Related]
10. Gene therapy in colon cancer cells with a fiber-modified adenovector expressing the TRAIL gene driven by the hTERT promoter. Jacob D; Bahra M; Schumacher G; Neuhaus P; Fang B Anticancer Res; 2004; 24(5A):3075-9. PubMed ID: 15517918 [TBL] [Abstract][Full Text] [Related]
11. Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter. Jacob D; Davis J; Zhu H; Zhang L; Teraishi F; Wu S; Marini FC; Fang B Clin Cancer Res; 2004 May; 10(10):3535-41. PubMed ID: 15161713 [TBL] [Abstract][Full Text] [Related]
13. [Killing effect of Ad.TERT-TRAIL on tumor cell lines and its mechanism]. Tang YX; Chen Y; Gu JF; Qi R; Zou WG; Jiang LL; Liu XY Ai Zheng; 2005 May; 24(5):536-42. PubMed ID: 15890093 [TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of TRAIL recombinant adenovirus in human malignant glioma cells. Kim KU; Seo SY; Heo KY; Yoo YH; Kim HJ; Lee HS; Choi SS; Hwang TH; Lee HJ J Korean Med Sci; 2005 Dec; 20(6):1046-52. PubMed ID: 16361820 [TBL] [Abstract][Full Text] [Related]
15. Gene therapy of pancreatic cancer with green fluorescent protein and tumor necrosis factor-related apoptosis-inducing ligand fusion gene expression driven by a human telomerase reverse transcriptase promoter. Katz MH; Spivack DE; Takimoto S; Fang B; Burton DW; Moossa AR; Hoffman RM; Bouvet M Ann Surg Oncol; 2003 Aug; 10(7):762-72. PubMed ID: 12900367 [TBL] [Abstract][Full Text] [Related]
16. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma. Ye X; Lu Q; Zhao Y; Ren Z; Ren XW; Qiu QH; Tong Y; Liang M; Hu F; Chen HZ Int J Mol Med; 2005 Dec; 16(6):1179-84. PubMed ID: 16273304 [TBL] [Abstract][Full Text] [Related]
17. [Adenoviral vector expressing the TRAIL gene driven by the hTERT promoter]. Jacob D; Davis J; Schumacher G; Bahra M; Neuhaus P; Fang B Z Gastroenterol; 2004 Dec; 42(12):1363-70. PubMed ID: 15592959 [TBL] [Abstract][Full Text] [Related]
18. A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases. Sova P; Ren XW; Ni S; Bernt KM; Mi J; Kiviat N; Lieber A Mol Ther; 2004 Apr; 9(4):496-509. PubMed ID: 15093180 [TBL] [Abstract][Full Text] [Related]
19. Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes. Lin T; Gu J; Zhang L; Huang X; Stephens LC; Curley SA; Fang B Cancer Res; 2002 Jul; 62(13):3620-5. PubMed ID: 12097263 [TBL] [Abstract][Full Text] [Related]
20. Adenoviral (full-length) Apo2L/TRAIL gene transfer is an ineffective treatment strategy for malignant glioma. Naumann U; Waltereit R; Schulz JB; Weller M J Neurooncol; 2003 Jan; 61(1):7-15. PubMed ID: 12587790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]